Notice: This company has been marked as potentially delisted and may not be actively trading. ARCA biopharma (ABIO) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for ARCA biopharma (NASDAQ:ABIO)CurrentInstitutional OwnershipPercentage56.44%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$12.12BNumber ofInstitutional Sellers(last 12 months)0 Get ABIO Insider Trade Alerts Want to know when executives and insiders are buying or selling ARCA biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABIO Institutional Buying and Selling by Quarter Ad Weiss RatingsNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. ARCA biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails9/16/2024 Cubist Systematic Strategies LLC27,779$106K0.0%N/A0.191% 8/16/2024 Perceptive Advisors LLC15,507,760$59.40M1.4%N/A106.898% 8/16/2024 Driehaus Capital Management LLC3,846,150$14.73M0.1%N/A26.512% 8/15/2024 Affinity Asset Advisors LLC72,484$278K0.0%N/A0.500% 8/14/2024 Cubist Systematic Strategies LLC27,779$106K0.0%N/A0.191% 8/9/2024 Renaissance Technologies LLC73,099$280K0.0%+11.3%0.504% Get the Latest News and Ratings for ABIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/7/2024 Cowen AND Company LLC700,000$2.68M0.1%N/A4.825% 2/20/2024 Cable Car Capital LLC4,000,452$6.80M7.6%N/A27.589% 1/31/2024 abrdn plc32,461$55K0.0%N/A0.000% 11/14/2023 Newtyn Management LLC300,000$603K0.1%-4.2%0.000% 4/14/2023 BML Capital Management LLC706,930$1.41M1.2%-17.6%0.000% 2/13/2023 BML Capital Management LLC858,256$2.03M1.9%N/A5.956% 2/10/2023 Murchinson Ltd.50,593$120K0.0%N/A0.351% 11/7/2022 Virtu Financial LLC14,221$29K0.0%N/A0.099% 7/27/2022 Bailard Inc.35,000$87K0.0%N/A0.243% 4/26/2022 Marquette Asset Management LLC17,318$40K0.0%N/A0.120% 2/10/2022 Acadian Asset Management LLC57,822$123K0.0%N/A0.401% 11/15/2021 GSA Capital Partners LLP441,945$1.31M0.1%+238.9%3.067% 11/15/2021 Minerva Advisors LLC10,000$30K0.0%N/A0.069% 11/9/2021BlackRock Inc.268,394$795K0.0%-1.8%1.863% 8/16/2021 State Street Corp69,037$241K0.0%N/A0.479% 8/13/2021 Geode Capital Management LLC87,659$305K0.0%+10.7%0.608% 8/13/2021 Vanguard Group Inc.398,507$1.39M0.0%+189.8%2.765% 8/12/2021 XTX Topco Ltd10,846$38K0.0%N/A0.075% 8/5/2021 GSA Capital Partners LLP130,395$455K0.1%+39.8%0.905% 5/19/2021 Virtu Financial LLC16,655$61K0.0%-32.4%0.116% 5/17/2021 PDT Partners LLC17,297$63K0.0%N/A0.120% 5/12/2021 Geode Capital Management LLC79,151$288K0.0%+141.7%0.549% 5/10/2021 GSA Capital Partners LLP93,241$340K0.1%+102.3%0.647% 2/24/2021 Virtu Financial LLC24,641$99K0.0%N/A0.264% 2/10/2021 Renaissance Technologies LLC205,500$824K0.0%+436.4%2.205% 2/10/2021 Panagora Asset Management Inc.6,878$28K0.0%N/A0.074% 2/4/2021 GSA Capital Partners LLP46,097$185K0.0%N/A0.495% 11/19/2020 Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195% 11/17/2020 Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195% 11/6/2020BlackRock Inc.287,263$1.27M0.0%+598,364.6%4.865% (Data available from 1/1/2016 forward) ABIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABIO shares? During the previous two years, 11 institutional investors and hedge funds held shares of ARCA biopharma. The most heavily invested institutionals were Perceptive Advisors LLC ($59.40M), Driehaus Capital Management LLC ($14.73M), Cable Car Capital LLC ($6.80M), Cowen AND Company LLC ($2.68M), BML Capital Management LLC ($1.41M), Newtyn Management LLC ($603K), and Renaissance Technologies LLC ($280K).Learn more on ABIO's institutional investors. What percentage of ARCA biopharma stock is owned by institutional investors? 56.44% of ARCA biopharma stock is owned by institutional investors. Learn more on ABIO's institutional investor holdings. Which institutional investors have been buying ARCA biopharma stock? Of the 10 institutional investors that purchased ARCA biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($15.51M), Cable Car Capital LLC ($4.00M), Driehaus Capital Management LLC ($3.85M), BML Capital Management LLC ($858.26K), Cowen AND Company LLC ($700K), Affinity Asset Advisors LLC ($72.48K), and Cubist Systematic Strategies LLC ($55.56K). How much institutional buying is happening at ARCA biopharma? Institutional investors have bought a total of 25,131,114 shares in the last 24 months. This purchase volume represents approximately $12.43B in transactions. Which ARCA biopharma major shareholders have been selling company stock? The following institutional investors have sold ARCA biopharma stock in the last 24 months: BML Capital Management LLC ($151.33K), and Newtyn Management LLC ($13.20K). How much institutional selling is happening at ARCA biopharma? Institutional investors have sold a total of 164,526 shares in the last 24 months. This volume of shares sold represents approximately $47.18M in transactions. Related Companies Atossa Therapeutics Major Shareholders InflaRx Major Shareholders Enanta Pharmaceuticals Major Shareholders Cabaletta Bio Major Shareholders Vaxart Major Shareholders Protalix BioTherapeutics Major Shareholders Cassava Sciences Major Shareholders Applied Therapeutics Major Shareholders Inventiva Major Shareholders Editas Medicine Major Shareholders This page (NASDAQ:ABIO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARCA biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
